Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.775 USD | +0.18% | -2.64% | -32.27% |
May. 13 | Morgan Stanley Lowers Price Target on Organogenesis Holdings to $3 From $3.50, Keeps Equalweight Rating | MT |
May. 10 | Health Care Edges Higher Amid Rotation to Utilities - Health Care Roundup | DJ |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.27% | 367M | |
+42.87% | 54.04B | |
+43.57% | 41.96B | |
-1.16% | 41.92B | |
-7.59% | 28.35B | |
+11.95% | 26.35B | |
-22.02% | 19B | |
+7.58% | 13B | |
+28.86% | 12.28B | |
+25.91% | 12.19B |
- Stock Market
- Equities
- ORGO Stock
- News Organogenesis Holdings Inc.
- Transcript : Organogenesis Holdings Inc., Q2 2023 Earnings Call, Aug 09, 2023